Actively Recruiting
Mitigating the Impact of Stigma and Shame Among People Living With HIV and Substance Use Disorders
Led by Boston University · Updated on 2026-05-13
256
Participants Needed
2
Research Sites
168 weeks
Total Duration
On this page
Sponsors
B
Boston University
Lead Sponsor
N
National Institute on Drug Abuse (NIDA)
Collaborating Sponsor
AI-Summary
What this Trial Is About
People living with HIV and substance use disorders (SUDs) are less likely to be virally suppressed, which can lead to HIV transmission and negative health outcomes. This hybrid type 1 study will assess the efficacy, mechanisms, as well as facilitators and barriers to implementing the MATTER intervention, a virtually delivered 5-session text-enhanced psychobehavioral intervention designed to facilitate viral suppression by addressing internalized stigma and shame as barriers to engagement in HIV care among individuals living with HIV and SUDs in two locations with different levels of HIV resources (i.e., the Boston, Massachusetts and Miami, Florida metro areas). MATTER aims to mitigate the negative behavioral consequences of internalized stigma and shame on viral suppression by a) developing behavioral self-care goal setting skills and related self-efficacy, b) increasing metacognitive awareness (i.e., non-judgmental awareness of emotions and cognitions), and c) teaching and reinforcing compassionate self-restructuring (i.e., self- compassion), in addition to providing access to phone-based resource navigation. Scalable interventions such as MATTER are essential to our efforts to end the HIV epidemic in high priority regions.
CONDITIONS
Official Title
Mitigating the Impact of Stigma and Shame Among People Living With HIV and Substance Use Disorders
Who Can Participate
Eligibility Criteria
You may qualify if you...
- HIV positive status
- Have a substance use disorder excluding only tobacco, cannabis, or alcohol
- Experience internalized stigma related to HIV, substance use, sexual orientation, or gender identity
- Have had a detectable viral load in the past year or report low adherence to oral or injectable ART as defined
- Be at least 18 years old
- Provide informed consent in English
- Be able to read and speak English or Spanish
- Provide proof of HIV positive status
- Agree to release HIV-related health records
- Have access to a cell phone with text messaging capabilities (phones and plans may be provided if needed)
You will not qualify if you...
- HIV negative status
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Florida International University
Miami, Florida, United States, 33199
Actively Recruiting
2
Fenway Health
Boston, Massachusetts, United States, 02215
Actively Recruiting
Research Team
A
Abigail Batchelder, PhD, MPH
CONTACT
A
Alexandria Miller, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here